88 related articles for article (PubMed ID: 27416621)
1. Body weight changes in children with idiopathic nephrotic syndrome.
Kuźma-Mroczkowska E; Pańczyk-Tomaszewska M; Skrzypczyk P; Artemiuk I; Roszkowska-Blaim M
Dev Period Med; 2016; 20(1):16-22. PubMed ID: 27416621
[TBL] [Abstract][Full Text] [Related]
2. Carotid intima-media thickness in children with idiopathic nephrotic syndrome: A single center cross-sectional study
.
Skrzypczyk P; Kuźma-Mroczkowska E; Kułagowska J; Brzewski M; Okarska-Napierała M; Pańczyk-Tomaszewska M
Clin Nephrol; 2019 Jun; 91(6):353-362. PubMed ID: 31079597
[TBL] [Abstract][Full Text] [Related]
3. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
Leonard MB; Feldman HI; Shults J; Zemel BS; Foster BJ; Stallings VA
N Engl J Med; 2004 Aug; 351(9):868-75. PubMed ID: 15329424
[TBL] [Abstract][Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
5. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
Gulati S; Godbole M; Singh U; Gulati K; Srivastava A
Am J Kidney Dis; 2003 Jun; 41(6):1163-9. PubMed ID: 12776267
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases.
Shiff NJ; Brant R; Guzman J; Cabral DA; Huber AM; Miettunen P; Roth J; Scuccimarri R; Alos N; Atkinson SA; Collet JP; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Lang B; Larche M; Leblanc C; Rodd C; Saint-Cyr C; Stein R; Stephure D; Taback S; Rauch F; Ward LM;
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):113-21. PubMed ID: 22826190
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome.
Foster BJ; Shults J; Zemel BS; Leonard MB
Pediatr Nephrol; 2006 Jul; 21(7):973-80. PubMed ID: 16773410
[TBL] [Abstract][Full Text] [Related]
8. Is the change in body mass index among children newly diagnosed with type 1 diabetes mellitus associated with obesity at transition from pediatric to adult care?
Manyanga T; Sellers EA; Wicklow BA; Doupe M; Fransoo R
Pediatr Diabetes; 2016 Dec; 17(8):599-607. PubMed ID: 26748829
[TBL] [Abstract][Full Text] [Related]
9. [Insulinsensitivity and beta-cell function in children with idiopathic nephrotic syndrome].
Tkaczyk M; Czupryniak A; Lukamowicz J; Ksiazek E; Półtorak-Krawczyk A; Swiatkowska E; Nowicki M
Przegl Lek; 2006; 63 Suppl 3():217-9. PubMed ID: 16898535
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome.
Nakamura A; Niimi R; Kurosaki K; Yanagawa Y
Clin Exp Nephrol; 2010 Oct; 14(5):457-62. PubMed ID: 20640586
[TBL] [Abstract][Full Text] [Related]
11. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
12. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.
Trachtman H; Greenbaum LA; McCarthy ET; Sharma M; Gauthier BG; Frank R; Warady B; Savin VJ
Am J Kidney Dis; 2004 Oct; 44(4):604-10. PubMed ID: 15384010
[TBL] [Abstract][Full Text] [Related]
13. Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone.
Saha MT; Laippala P; Lenko HL
Acta Paediatr; 1998 May; 87(5):545-8. PubMed ID: 9641737
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
[TBL] [Abstract][Full Text] [Related]
15. Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids.
Wasilewska AM; Zoch-Zwierz WM; Pietruczuk M
Eur J Pediatr; 2006 Dec; 165(12):839-44. PubMed ID: 16738866
[TBL] [Abstract][Full Text] [Related]
16. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
[TBL] [Abstract][Full Text] [Related]
18. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
Tanvig M
Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
[TBL] [Abstract][Full Text] [Related]
19. Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease.
Burnham JM; Shults J; Petit MA; Semeao E; Beck TJ; Zemel BS; Leonard MB
J Bone Miner Res; 2007 Apr; 22(4):551-9. PubMed ID: 17243860
[TBL] [Abstract][Full Text] [Related]
20. Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study.
Hitze B; Bosy-Westphal A; Bielfeldt F; Settler U; Plachta-Danielzik S; Pfeuffer M; Schrezenmeir J; Mönig H; Müller MJ
Eur J Clin Nutr; 2009 Jun; 63(6):739-46. PubMed ID: 18665183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
